Clinical Trial

Effect of Chitodex Gel in Tympanoplasty Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 13, 2024 (before its estimated May 13, 2025 completion). Its status may not reflect the trial's current state.
Summary
The general purpose of this study is to compare Chitosan-dextran (Chitodex) gel versus current standard of care, Gelfoam, as a middle ear (ME) and external auditory canal (EAC) packing agent as part of tympanoplasty, ossiculoplasty and mastoidectomy procedures.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-07; most recent amendment 2024-11-11.
Trial Details
NCT Number NCT06260618
Lead Sponsor Central Adelaide Local Health Network Incorporated
Collaborators: University of Adelaide
Conditions Tympanic Membrane Perforation, Tympanic Membrane Inflammation, Surgery, Otitis Media
Enrollment 44 participants
Start Date 2021-11-20
Primary Completion 2025-05-13 (estimated)
Study Completion 2025-05-13 (estimated)
Updated on ClinicalTrials.gov 2024-11-13